Long/short equity, research analyst, biotech, healthcare

Is Vringo A Lottery Ticket Or An Investment?

Ever since Vringo (VRNG) won its patent infringement case against Google (NASDAQ:GOOG) last November, shares of the company have had a tough time. Namely, VRNG shares are down more than 36% since "winning" their initial patent infringement case, which was supposed to set a precedent for future enforcement activities. This downturn in the stock has been caused, in part, by what shareholders view as undue delays in the case stemming from a clear lack of judgments emanating from the Eastern District of Virginia Courtroom. Indeed, I even penned an article a while back suggesting the key ruling for both parties, i.e. the "Running Royalty Rate", had a good chance of being handed down in May of this year....

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details